- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04255732
Comparison of Wide-field Retinal Imaging
Comparison Between Two Wide-field Imaging Systems on the Extent of Retinal Periphery Area Viewing
Fundus imaging has become an integral tool in retinal diagnosis. Although single-field fundus photography covers a vital region of the retina, it leaves a large portion of the periphery undiscovered.
Ultra-wide-field imaging systems allowed for visualization of peripheral perfusion abnormalities in myopic eyes that were previously unknown.
In Austria, there are two different wide-field imaging systems available. The first device on the market was the Optos (Optos PLC, Dunfermline, UK) and several years later the Clarus 500 (Carl Zeiss, Meditec AG, Jena, Germany) was introduced.
Study Overview
Status
Conditions
Detailed Description
While both of the studied imaging systems have the possibility of a 200° view of the retina, we would asses if the differences between the two devices affect the extent of retinal periphery view and if ocular ametropies which come with different retinal pathologies would affect the retinal periphery assessment.
Aim: To compare two CE-marked imaging systems concerning the extent of retinal periphery area viewing.
We would like to perform a prospective observational study that would include patients divided into three groups: myopic patients, hyperopic and emmetropic patients.
Fundus photography will be performed using two ultra-wide-field imaging systems (Optos, Daytona, Optos PLC, Dunfermline, UK and Clarus, 500 Carl Zeiss, Meditec AG, Jena, Germany), performed by the same investigator.
All images with sufficient quality will be exported and saved to hard-disk. The difference in periphery view will be investigated as follows: two retinal photos for each patient will be imported into Photoshop CS6 image-editing system (Adobe, version 13.0.0) where the anatomical landmarks will be matched for each image and the borders will be compared to see if there are differences in retinal periphery area viewing between the two devices.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Vienna, Austria, 1140
- Recruiting
- Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient over 21 years old
- Myopic (at least -5.00Dsph), hyperopic (over +3.00Dsph) and emmetropic patients
- Written informed consent prior to any study specific action.
Exclusion Criteria:
- Extensive cataract or severe corneal scaring that would affect image quality
- Fixation problems, nystagmus
- pregnancy- for women in reproductive age a pregnancy test will be performed.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Extent of retinal periphery area viewing
For the 30 patients fundus photography will be performed using two ultra-wide-field imaging systems.
|
Comparison of the extent of retinal periphery view between two wide field imaging devices.
Comparison of the extent of retinal periphery view between two wide field imaging devices.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
difference in retinal periphery viewing between the two devices
Time Frame: 7 months
|
Extent of retinal periphery area viewing (the difference in periphery area between the two devices).
Images of the same patients will be compared to determine the degree of periphery viewing for the two devices.
|
7 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UWF (Other Identifier: University of Wisconsin Foundation)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retinal Disease
-
LKC Technologies, Inc.Completed
-
University Hospital, Strasbourg, FranceCompletedInherited Retinal DiseaseFrance
-
Indiana UniversityCompleted
-
Retinagenix HoldingsWithdrawnRetinal DisorderUnited States
-
Center for Eye Research AustraliaTerminated
-
Janssen Research & Development, LLCActive, not recruitingInherited Retinal DiseasesUnited States, Germany, United Kingdom, Italy, Japan, Belgium, France, China, Spain, Israel, Canada, Australia, Austria, Switzerland, Brazil, Finland, South Korea, Denmark
-
University Hospital Inselspital, BerneCompletedRetinal DiseaseSwitzerland
-
Topcon Medical Systems, Inc.CompletedNormal Eyes | Eyes With Glaucoma | Eyes With Retinal DiseaseUnited States
-
Peking Union Medical College HospitalRecruitingInherited Retinal DiseasesChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...CompletedInherited Retinal DiseasesChina